SUN bioscience is enabling standardization of organoid cultures through SUN’s proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development.
Our flagship technology Gri3D® is solving the challenges of organoid culture: automation, robustness, scalability, and easy imaging. This will introduce a new era in drug development